Literature DB >> 5120247

Bacterial endocarditis over prosthetic valves treated with trimethoprim-sulphamethoxazole combination.

S H Shafqat, S A Shah, S A Seyed.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5120247      PMCID： PMC458459          DOI： 10.1136/hrt.33.6.974

Source DB:  PubMed          Journal:  Br Heart J        ISSN： 0007-0769


× No keyword cloud information.
  3 in total

1.  [TRIAL TREATMENT OF VARIOUS "PROTEUS" INFECTIONS WITH 2,4-DIAMINO-5-(3,4,5-TRIMETHOXYBENZYL) PYRIMIDINE, OR (TRIM'ETHOPRIME)].

Authors:  M SCHNEIDER; L SCHWARZENBERG; A CATTAN; J R SCHLUMBERGER; J L AMIEL; G MATHE
Journal:  Presse Med       Date:  1965-03-27       Impact factor: 1.228

2.  Erythrocillin: a new approach to the problem of antibiotic-resistant staphylococci.

Authors:  W E HERRELL; A BALOWS; J BECKER
Journal:  Antibiotic Med Clin Ther (New York)       Date:  1960-10

3.  Cardiac surgery and bacterial endocarditis.

Authors:  M V Braimbridge
Journal:  Lancet       Date:  1969-06-28       Impact factor: 79.321
  3 in total
  3 in total

1.  Pseudomonas cepacia endocarditis treated with co-trimoxazole and kanamycin.

Authors:  D C Speller
Journal:  Br Heart J       Date:  1973-01

2.  Treatment of experimental endocarditis due to methicillin-susceptible or methicillin-resistant Staphylococcus aureus with trimethoprim-sulfamethoxazole and antibiotics that inhibit cell wall synthesis.

Authors:  M de Górgolas; P Avilés; C Verdejo; M L Fernández Guerrero
Journal:  Antimicrob Agents Chemother       Date:  1995-04       Impact factor: 5.191

Review 3.  A new strategy to fight antimicrobial resistance: the revival of old antibiotics.

Authors:  Nadim Cassir; Jean-Marc Rolain; Philippe Brouqui
Journal:  Front Microbiol       Date:  2014-10-20       Impact factor: 5.640
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.